Lorenzo Cervantes, MD
Ophthalmology · Shelton, CTNPI 1962615922
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 31.8% of the total. Among ophthalmology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $68.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$5K
- Eyevance Pharmaceuticals LLC$4K
- Sun Pharmaceutical Industries Inc.$2K
- Harrow Eye, LLC$1K
- Tarsus Pharmaceuticals, Inc.$990
- Alcon$703
- plus $3K from 22 others
What the payments were for
- Consulting fees$2,47516%
- Speaking & faculty fees$3,85024%
- Travel & lodging$1421%
- Food & beverage$9,41759%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 26 | $5,059 |
| Eyevance Pharmaceuticals LLC | 23 | $3,660 |
| Sun Pharmaceutical Industries Inc. | 44 | $1,599 |
| Harrow Eye, LLC | 28 | $1,356 |
| Tarsus Pharmaceuticals, Inc. | 17 | $990 |
| Alcon | 22 | $703 |
| Dompe US, Inc. | 15 | $614 |
| Oyster Point Pharma, Inc. | 13 | $477 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $238 |
| Rxsight Inc | 4 | $214 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $207 |
| Carl Zeiss Meditec, Inc. | 1 | $121 |
| Rayner Intraocular Lenses Limited | 5 | $95 |
| Shire North American Group Inc | 3 | $92 |
| Thea Pharma Inc. | 2 | $66 |
| Amgen | 3 | $62 |
| Ocular Therapeutix, Inc. | 3 | $54 |
| Sight Sciences, Inc. | 2 | $47 |
| Kala Pharmaceuticals, Inc. | 2 | $45 |
| Lombart Brothers, Inc. | 1 | $25 |
| Novartis | 1 | $25 |
| Biotissue Holdings Inc. | 1 | $23 |
| Glaukos Corporation | 1 | $23 |
| CSL Behring | 1 | $23 |
| Eyepoint US, Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IC-8 Apthera IOL$4,201
- enVista MX60 IOL$4,075
- Flarex$1,533
- Tobradex ST$1,035
- Zerviate$755
- CEQUA$490
- XDEMVY$375
- Oxervate$250
- TYRVAYA$208
- RXSIGHT CONTACT LENS$144
- RXSIGHT INJECTOR HANDPIECE$144
- RXSIGHT INJECTOR CARTRIDGE$144
- LIGHT ADJUSTABLE LENS (LAL)$144
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$144
- Tecnis IOL$134
- ENVISTA$133
- STELLARIS$133
- enVista Aspire IOL$131
- MIEBO$125
- XIIDRA$125
How this compares
$15,885 in reported general payments places this provider in the 95th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 34 | $57,028 |
| XdemvyLotilaner | 27 | $51,152 |
| CequaCyclosporine | 19 | $27,098 |
| MieboPerfluorohexyloctane/Pf | 27 | $20,050 |
| Difluprednate | 179 | $16,293 |
| Prednisolone Acetate | 511 | $15,801 |
| Gatifloxacin | 398 | $15,235 |
| Fluorometholone | 170 | $12,126 |
| TyrvayaVarenicline Tartrate | 12 | $9,207 |
| LumiganBimatoprost | 12 | $7,381 |
| DurezolDifluprednate | 32 | $6,999 |
| FlarexFluorometholone Acetate | 43 | $5,776 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $5,508 |
| ValacyclovirValacyclovir Hcl | 99 | $5,112 |
| Ofloxacin | 164 | $1,684 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $12 | $69,91861 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $990 | $51,15227 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $1,599 | $27,09819 claims |
| Bausch & Lomb Americas Inc.Miebo | $5,059 | $20,05027 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $477 | $9,20712 claims |
| NovartisDurezol | $25 | $6,99932 claims |
| Eyevance Pharmaceuticals LLCFlarex | $3,660 | $5,77643 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 279 ophthalmology providers in Connecticut.
Other ophthalmology in Shelton
- John HuangHartford$267K
- Amir CohenNew Haven$266K
- James MurphyHamden$176K
- James TalbotNew Canaan$47K
- Paul KangNew Haven$40K
- Anish ShahNorwich$38K
- Michael KovalFarmington$35K
- Scott SpectorNorwalk$23K
- Madina FalconeFarmington$23K
- Flora LevinBridgeport$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.